This monograph is based on a symposium about the EX-PRESS Glaucoma Filtration Device (Alcon Laboratories, Inc., Fort Worth, TX; Figure 1) that was held during the American Glaucoma Society meeting in Dana Point, California, in March of this year. The purpose of the symposium was to feature advances in glaucoma surgery that may benefit glaucoma patients because, ultimately, what is good for our patients is good for us. I feel that the EX-PRESS device is one of the more exciting of these advances, because it has the potential to standardize filtration in glaucomatous eyes.
The EX-PRESS Glaucoma Filtration Device is indicated to reduce IOP in glaucoma patients where medical and conventional surgical treatments have failed. It is my pleasure to work with Marlene Moster, MD, who participated in the device's clinical trials and has excellent data. I think you will find the information presented herein quite interesting and useful for your practice.
—Robert D. Fechtner, MD
Director of the Glaucoma Division at the
University of Medicine and Dentistry, Newark, New Jersey
